Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
New findings reported from Massachusetts General Hospital describe advances in HIV/AIDS
June 21st, 2009
"Expectations regarding receipt of medications and medical care after clinical trials conclude may inform decisions about trial participation. We describe the frequency with which these posttrial services are described in the protocols and informed consent forms (ICFs) of antiretroviral drug (ARV) trials," researchers in the United States report. "We systematically reviewed protocols and ICFs from Phase 3 and 4 antiretroviral trials in adults (>= 2 years) from 1987 to 2006. Pharmaceutical industry-sponsored trials were selected from US Food and Drug Administration (FDA) documentation and Clinicaltrials.gov. Trials administered by the AIDS Clinical Trials Group (ACTG)...
Source: Medical Letter on the CDC & FDA (2009-06-21)
|
